Assignee
NEURALAB LTD
US·27 granted patents·17 pending applications·3,449 citations·filing 1998–2008
Top patents by PatentIndex Score
44 records- 0199US7014855B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Mar 21, 2006·122 cites·63 claims
- 0299US6972127B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Dec 6, 2005·120 cites·120 claims
- 0399US6913745B1Passive immunization of Alzheimer's diseaseNEURALAB LTD·Filed 2000·Granted Jul 5, 2005·142 cites·60 claims
- 0499US6875434B1Methods of treatment of Alzheimer's diseaseNEURALAB LTD·Filed 2000·Granted Apr 5, 2005·191 cites·58 claims
- 0599US6866850B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Mar 15, 2005·145 cites·80 claims
- 0699US6866849B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Mar 15, 2005·155 cites·60 claims
- 0799US6743427B1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2000·Granted Jun 1, 2004·281 cites·19 claims
- 0898US6982084B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Jan 3, 2006·85 cites·34 claims
- 0998US6962707B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Nov 8, 2005·64 cites·42 claims
- 1098US6946135B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Sep 20, 2005·74 cites·60 claims
- 1198US6905686B1Active immunization for treatment of alzheimer's diseaseNEURALAB LTD·Filed 2000·Granted Jun 14, 2005·120 cites·46 claims
- 1298US6890535B1Pharmaceutical compositions and methods for treatment of amyloid diseasesNEURALAB LTD·Filed 2000·Granted May 10, 2005·130 cites·57 claims
- 1398US6787143B1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2000·Granted Sep 7, 2004·96 cites·24 claims
- 1498US6787139B1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2000·Granted Sep 7, 2004·114 cites·70 claims
- 1598US6787637B1N-Terminal amyloid-β antibodiesNEURALAB LTD·Filed 2000·Granted Sep 7, 2004·202 cites·7 claims
- 1698US6787140B1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2000·Granted Sep 7, 2004·111 cites·43 claims
- 1798US6787144B1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2000·Granted Sep 7, 2004·116 cites·24 claims
- 1898US6787138B1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2000·Granted Sep 7, 2004·113 cites·36 claims
- 1998US6761888B1Passive immunization treatment of Alzheimer's diseaseNEURALAB LTD·Filed 2000·Granted Jul 13, 2004·228 cites·36 claims
- 2098US6750324B1Humanized and chimeric N-terminal amyloid beta-antibodiesNEURALAB LTD·Filed 2000·Granted Jun 15, 2004·202 cites·12 claims
- 2198US6710226B1Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristicsNEURALAB LTD·Filed 2000·Granted Mar 23, 2004·163 cites·32 claims
- 2297US6818218B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Nov 16, 2004·58 cites·38 claims
- 2397US6808712B2Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Granted Oct 26, 2004·53 cites·29 claims
- 2497US6787523B1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 1998·Granted Sep 7, 2004·154 cites·24 claims
- 2596US7189819B2Humanized antibodies that recognize beta amyloid peptideNEURALAB LTD·Filed 2001·Granted Mar 13, 2007·117 cites·63 claims
- 2696US6923964B1Active immunization of AScr for prion disordersNEURALAB LTD·Filed 2000·Granted Aug 2, 2005·75 cites·10 claims
- 2789US6936246B1Passive immunization of ASCR for prion disordersNEURALAB LTD·Filed 2000·Granted Aug 30, 2005·18 cites·12 claims
- 2869US2005255122A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 2968US2004247590A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 3068US2005158304A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 3168US2009297511A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2008·Application pending·0 cites
- 3267US2004247591A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 3367US2004265301A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 3467US2006121038A9Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 3565US2004081657A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2003·Application pending·0 cites
- 3664US2005019328A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 3763US2006034858A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2005·Application pending·0 cites
- 3863US2006029611A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2005·Application pending·0 cites
- 3962US2005191314A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2005·Application pending·0 cites
- 4062US2005142132A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2005·Application pending·0 cites
- 4159US2004265308A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 4259US2004219146A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 4354US2005059802A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
- 4454US2005059591A1Prevention and treatment of amyloidogenic diseaseNEURALAB LTD·Filed 2004·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →